Persones / Equip Humà

Lourdes Ibañez Toda

Buscador de publicacions

Publicacions

  • Ibañez-Toda L, Suárez L, Lopez-Bermejo A, Díaz-Silva M, Valls C and de Zegher F.

    Early development of visceral fat excess after spontaneous catch-up growth in children with low birth weight

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 93(3): 925-928. Nº de cites: 135

    [doi:10.1210/jc.2007-1618]

  • Ibañez-Toda L, López-Bermejo A, Díaz-Silva M, Enríquez G, Valls C and de Zegher F.

    Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess:: additional increments of visfatin and high molecular weight adiponectin

    CLINICAL ENDOCRINOLOGY . 68(2): 317-320. Nº de cites: 26

    [doi:10.1111/j.1365-2265.2007.03137.x]

  • López-Bermejo A, de Zegher F, Díaz-Silva M, Vicente MP, Valls C and Ibañez-Toda L.

    Cord serum visfatin at term birth:: maternal smoking unmasks the relation to foetal growth

    CLINICAL ENDOCRINOLOGY . 68(1): 77-81. Nº de cites: 14

    [doi:10.1111/j.1365-2265.2007.03002.x]

  • Ibañez-Toda L, López-Bermejo A, Callejo J, Torres A, Cabré-Gili S, Dunger D and de Zegher F.

    Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess:: Relation to prenatal growth

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 93(1): 196-199. Nº de cites: 31

    [doi:10.1210/jc.2007-1800]

  • Ong KK, de Zegher F, López-Bermejo A, Dunger DB and Ibañez-Toda L.

    Flutamide-metformin for post-menarcheal girls with preclinical ovarian androgen excess:: evidence for differential response by androgen receptor genotype

    EUROPEAN JOURNAL OF ENDOCRINOLOGY . 157(5): 661-668. Nº de cites: 11

    [doi:10.1530/EJE-07-0261]

  • López-Bermejo A, Casano-Sancho P, Petry CJ, Jaramillo AM, Rodríguez-González FX, Dunger DB, de Zegher F and Ibañez-Toda L.

    Insulin resistance after precocious pubarche:: relation to PAI-1-675 4G/5G polymorphism, and opposing influences of prenatal and postnatal weight gain

    CLINICAL ENDOCRINOLOGY . 67(4): 493-499. Nº de cites: 5

    [doi:10.1111/j.1365-2265.2007.02914.x]

  • Ong K, de Zegher F, Valls C, Dunger DB and Ibañez-Toda L.

    Persisting benefits 12-18 months after discontinuation of pubertal metformin therapy in low birthweight girls

    CLINICAL ENDOCRINOLOGY . 67(3): 468-471. Nº de cites: 14

    [doi:10.1111/j.1365-2265.2007.02952.x]

  • Argente J, Gracia R, Ibañez-Toda L, Oliver A, Borrajo E, Vela A, López-Siguero JP, Moreno ML and Rodríguez-Hierro F.

    Improvement in growth after two years of growth hormone therapy in very young children born small for gestational age and without spontaneous catch-up growth:: Results of a multicenter, controlled, randomized, open clinical trial

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 92(8): 3095-3101. Nº de cites: 36

    [doi:10.1210/jc.2007-0078]

  • Petry CJ, Ong KK, Wingate DL, de Zegher F, Ibañez-Toda L and Dunger DB.

    Lack of association between common polymorphisms in the 17ß-hydroxy steroid dehydrogenase type V gene (HSD17B5) and precocious pubarche

    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY . 105(1-5): 176-180. Nº de cites: 16

    [doi:10.1016/j.jsbmb.2007.01.004]

  • Ibañez-Toda L, López-Bermejo A, del Rio L, Enríquez G, Valls C and de Zegher F.

    Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM . 92(5): 1710-1714. Nº de cites: 41

    [doi:10.1210/jc.2006-2684]